Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Zeria designs dual-action arylpiperazines for BPH

June 28, 1999

WAY-133537: safe and effective agent for bladder instability

June 28, 1999

Merck describes new selective alpha1a-adrenoceptor blockers and use in BPH

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Substantially pure (S)-(+)-enantiomer form of ETA antagonist prepared at Pfizer

June 15, 1999

Imidazotriazinones synthesized at Bayer inhibit cGMP-PDE isozymes

June 14, 1999

Tricyclic cGMP-PDE inhibitors for urinary incontinence and related disorders

June 8, 1999

New compounds from SS Pharm. with greater bladder selectivity than oxybutynin

June 7, 1999

Kissei presents binding profile and functional characterization of alpha1-adrenoceptor antagonist

June 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.